2026 Q3 Portfolio Activity
In 2026 Q3, GSK plc maintained a portfolio of 13 distinct positions. The fund also reduced its exposure to BIONTECH SE by 24.9%.
Position History
hover any row below to update
Loading…
Total Positions
13
Quarter
2026 Q3
Top Holding
CRSP (29.0%)
Top 10 Concentration
98.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13
GSK plc Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CRSP
CRISPR THERAPEU...
|
Healthcare | 29.03% | 29.17% |
#1
Prev: #1
|
6.5 |
—
|
-612,208 | -19.0% |
P
S
|
2,608,419 | $144,297,739 |
$52.44
-19.5%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | ||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 19.23% | 14.47% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
8,550,954 | $95,599,666 |
$6.03
+65.2%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | ||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 13.58% | 17.60% |
#3
1
Prev: #2
|
6.0 |
—
|
no change | no change |
P
S
|
18,245,691 | $67,509,057 |
$17.00
-81.6%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | ||
|
BNTX
BIONTECH SE
|
Healthcare | 13.22% | 13.75% |
#4
Prev: #4
|
4.5 |
—
|
-221,298 | -24.9% |
P
S
|
668,526 | $65,716,106 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 10.31% | 8.25% |
#5
Prev: #5
|
5.5 |
—
|
no change | no change |
P
S
|
1,333,333 | $51,226,654 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 4.51% | 4.82% |
#6
Prev: #6
|
2.8 |
—
|
no change | no change |
P
S
|
340,434 | $22,438,005 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 2.98% | 3.53% |
#7
Prev: #7
|
2.2 |
—
|
no change | no change |
P
S
|
1,512,659 | $14,808,932 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
SPRO
SPERO THERAPEUT...
|
Healthcare | 2.24% | 3.37% |
#8
Prev: #8
|
1.9 |
—
|
no change | no change |
P
S
|
9,190,606 | $11,120,633 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
NKTX
NKARTA INC
|
Healthcare | 1.66% | 1.48% |
#9
Prev: #9
|
1.7 |
—
|
no change | no change |
P
S
|
3,150,732 | $8,254,918 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 1.33% | 1.09% |
#10
Prev: #10
|
1.5 |
—
|
no change | no change |
P
S
|
1,785,714 | $6,607,142 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
BCYC
BICYCLE THERAPE...
|
Healthcare | 1.13% | 1.08% |
#11
Prev: #11
|
1.5 |
—
|
no change | no change |
P
S
|
1,529,561 | $5,628,784 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 0.41% | 0.54% |
#12
1
Prev: #13
|
1.2 |
—
|
no change | no change |
P
S
|
271,456 | $2,044,064 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 | |||
|
CVRX
CVRX INC
|
Healthcare | 0.35% | 0.86% |
#13
1
Prev: #12
|
1.1 |
—
|
no change | no change |
P
S
|
1,007,583 | $1,763,270 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-05 |
Showing 1-13 of 13 holdings